CLB

$9.552.25%-0.22

Dopo l'orario di chiusura: 9.77+0.22 +2.30%

Core Laboratories Inc (CLB)

Date: O: H: L: C: Vol:

Precedente Chiudi:

$9.77

Aprire:

$9.85

Volume 24 ore:

130,658

Volume relativo:

0.16

Capitalizzazione di mercato:

$437.61M

Reddito:

$524.73M

Utile/perdita netta:

$31.70M

Rapporto P/E:

14.43

EPS:

$0.6617

Flusso di cassa netto:

$22.47M

1W Prestazione:

-8.96%

1M Prestazione:

-3.73%

6M Prestazione:

-30.70%

1Y Prestazione:

-39.67%

Intervallo 1D:

$9.54$9.88

Intervallo di 1 settimana:

$9.47$10.79

Portata 52W:

$9.13$20.36

Profilo aziendale di Core Laboratories Inc (CLB)

Nome

Core Laboratories Inc

Settore

Energy

Industria

Oil & Gas Equipment & Services

Telefono

713-328-2673

Indirizzo

6316 WINDFERN ROAD, HOUSTON, USA

Dipendente

3,300

@corelabcompany

Prossima data di guadagno

null

Ultimi documenti SEC

SEC

Discussioni di CLB su X

Cap. di mercato

Reddito

Reddito netto

Flusso di cassa

EPS

Core Laboratories Inc Azioni (CLB) Upgrade e downgrade

Data	Azione	Analista	Modifica della valutazione
2026-08-13	Aggiornamento	Johnson Rice	Hold → Buy
2025-03-12	Aggiornamento	Citigroup	Sell → Neutral
2023-06-30	Downgrade	Citigroup	Neutral → Sell
2023-04-18	Downgrade	BofA Securities	Neutral → Underperform
2023-01-09	Aggiornamento	BofA Securities	Underperform → Neutral
2022-10-07	Aggiornamento	Citigroup	Sell → Neutral
2022-09-26	Downgrade	Morgan Stanley	Equal-Weight → Underweight
2022-04-18	Downgrade	Piper Sandler	Neutral → Underweight
2021-10-18	Downgrade	BofA Securities	Neutral → Underperform
2021-07-09	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2021-06-14	Downgrade	Citigroup	Neutral → Sell
2020-12-18	Downgrade	JP Morgan	Neutral → Underweight
2020-11-11	Reiterato	Cowen	Market Perform
2020-10-13	Aggiornamento	BofA Securities	Underperform → Neutral
2020-09-29	Aggiornamento	ABN Amro	Sell → Hold
2020-07-16	Downgrade	Scotiabank	Sector Outperform → Sector Perform
2020-04-13	Aggiornamento	Scotiabank	Sector Perform → Sector Outperform
2020-03-09	Downgrade	BofA/Merrill	Buy → Underperform
2020-03-09	Downgrade	Evercore ISI	Outperform → In-line
2020-01-31	Reiterato	Cowen	Market Perform
2020-01-30	Resumed	Johnson Rice	Buy
2020-01-14	Iniziato	Bernstein	Mkt Perform
2020-01-02	Downgrade	Stifel	Buy → Hold
2019-12-31	Reiterato	Cowen	Market Perform
2019-07-10	Aggiornamento	BofA/Merrill	Neutral → Buy
2019-02-25	Aggiornamento	Tudor Pickering	Hold → Buy
2018-12-19	Downgrade	Credit Suisse	Outperform → Neutral
2018-12-11	Downgrade	JP Morgan	Overweight → Neutral
2018-11-16	Aggiornamento	Guggenheim	Neutral → Buy
2018-11-01	Aggiornamento	ABN Amro	Sell → Buy
2018-10-29	Reiterato	Cowen	Market Perform

Core Laboratories Inc Azioni (CLB) Dati Finanziari

Periodo	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Data di fine periodo	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue USD (M)	526.52	523.85	509.79	489.74	470.25
Cost of revenue USD (M)	417.59	420.52	-	-	-
Operating expenses USD (M)	-	-	455.15	448.21	424.99
Operating income USD (M)	56.47	58.56	54.64	41.52	45.26
Income before tax USD (M)	45.90	46.19	41.21	29.95	36.11
Income tax expense USD (M)	15.51	14.03	-4.19	10.30	15.89
Net income USD (M)	30.39	32.15	37.03	19.66	20.22
Basic EPS USD/shares	0.64	0.67	0.79	0.42	0.43
Diluted EPS USD/shares	0.63	0.66	0.77	0.42	0.42
Basic weighted shares shares (M)	46.43	46.90	46.68	46.33	46.01
Diluted weighted shares shares (M)	47.03	47.69	47.52	46.81	46.69

Core Laboratories Inc Azioni (CLB) insider trading

Tattoli Mark DamianOct 01 '26
SVP, Gen Counsel & Secretary
Transazione
Option Exercise
Costo
$0.00
#Azioni
700
Valore ($)
0
#Azioni Totale
28,365
Teo Sow HangOct 01 '26
CAO & Treasurer
Transazione
Option Exercise
Costo
$0.00
#Azioni
250
Valore ($)
0
#Azioni Totale
8,917
Teo Sow HangAug 01 '26
CAO & Treasurer
Transazione
Option Exercise
Costo
$0.00
#Azioni
440
Valore ($)
0
#Azioni Totale
8,775
Tattoli Mark DamianAug 01 '26
SVP, Gen Counsel & Secretary
Transazione
Option Exercise
Costo
$0.00
#Azioni
250
Valore ($)
0
#Azioni Totale
27,764
Bruno LawrenceJul 31 '26
Chairman and CEO
Transazione
Buy
Costo
$10.78
#Azioni
5,000
Valore ($)
53,900
#Azioni Totale
262,438
Tattoli Mark DamianMay 01 '26
SVP, Gen Counsel & Secretary
Transazione
Option Exercise
Costo
$0.00
#Azioni
250
Valore ($)
0
#Azioni Totale
27,611
Temeng KwakuApr 01 '26
Director
Transazione
Option Exercise
Costo
$0.00
#Azioni
8,069
Valore ($)
0
#Azioni Totale
33,597
Murray KatherineApr 01 '26
Director
Transazione
Option Exercise
Costo
$0.00
#Azioni
8,069
Valore ($)
0
#Azioni Totale
29,290
ANASTASIO CURTApr 01 '26
Director
Transazione
Option Exercise
Costo
$0.00
#Azioni
8,069
Valore ($)
0
#Azioni Totale
23,805
Klingensmith Harvey RobertApr 01 '26
Director
Transazione
Option Exercise
Costo
$0.00
#Azioni
8,069
Valore ($)
0
#Azioni Totale
50,031

Commercio interno	Relazione	Data	Transazione	Costo	#Azioni	Valore ($)	#Azioni Totale
Tattoli Mark Damian	SVP, Gen Counsel & Secretary	Oct 01 '26	Option Exercise	$0.00	700	0	28,365
Teo Sow Hang	CAO & Treasurer	Oct 01 '26	Option Exercise	$0.00	250	0	8,917
Teo Sow Hang	CAO & Treasurer	Aug 01 '26	Option Exercise	$0.00	440	0	8,775
Tattoli Mark Damian	SVP, Gen Counsel & Secretary	Aug 01 '26	Option Exercise	$0.00	250	0	27,764
Bruno Lawrence	Chairman and CEO	Jul 31 '26	Buy	$10.78	5,000	53,900	262,438
Tattoli Mark Damian	SVP, Gen Counsel & Secretary	May 01 '26	Option Exercise	$0.00	250	0	27,611
Temeng Kwaku	Director	Apr 01 '26	Option Exercise	$0.00	8,069	0	33,597
Murray Katherine	Director	Apr 01 '26	Option Exercise	$0.00	8,069	0	29,290
ANASTASIO CURT	Director	Apr 01 '26	Option Exercise	$0.00	8,069	0	23,805
Klingensmith Harvey Robert	Director	Apr 01 '26	Option Exercise	$0.00	8,069	0	50,031

Core Laboratories Inc Borsa (CLB) Ultime notizie

Nov 03, 2026

CLB Q3 Earnings Miss Estimates on Higher Costs and Disruptions - TradingView

Nov 03, 2026

CLB Q3 Earnings Miss Estimates on Higher Costs and Disruptions - Zacks Investment Research

Nov 03, 2026

Nov 02, 2026

Core Laboratories N.V. (CLB) Seasonal returns chart - Yahoo Finance UK

Nov 02, 2026

Weekly Recap: Revenue growth and Reservoir Description margin gain - TradingView

Nov 02, 2026

Oct 31, 2026

The most interesting analyst questions from Core Laboratories’s Q3 earnings call - Yahoo Finance

Oct 31, 2026